Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain
- 1 January 1992
- Vol. 10 (7), 443-446
- https://doi.org/10.1016/0264-410x(92)90392-w
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Construction of genetically defined double aro mutants of Salmonella typhiVaccine, 1991
- Lack of Immune Response to the Vi Component of a Vi-Positive Variant of the Salmonella typhi Live Oral Vaccine Strain Ty21a in Human StudiesThe Journal of Infectious Diseases, 1991
- Oral vaccination of calves against experimental salmonellosis using a double aro mutant of Salmonella typhimuriumVaccine, 1991
- Clinical and field trials with attenuated Salmonella typhi as live oral vaccines and as “carrier” vaccinesResearch in Microbiology, 1990
- IDENTIFICATION OF AN INTESTINAL IMMUNE RESPONSE USING PERIPHERAL BLOOD LYMPHOCYTESThe Lancet, 1988
- Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans.Journal of Clinical Investigation, 1987
- Live oral Salmonella vaccines: potential use of attenuated strains as carriers of heterologous antigens to the immune systemParasite Immunology, 1987
- Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccinesNature, 1981
- RUBELLA VIRAEMIA AND ANTIBODY RESPONSES AFTER RUBELLA VACCINATION AND REIMMUNISATIONThe Lancet, 1981
- Typhoid tonsillitisPublished by American Medical Association (AMA) ,1980